Rocket Pharmaceuticals, Inc. (RCKT) Free cash flow 2016–2025
Rocket Pharmaceuticals, Inc. (RCKT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$190.5MFY2025 · since FY2016: -$5.8M → -$190.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.5M | +11.7% |
| FY2024 | -$215.6M | -2.0% |
| FY2023 | -$211.4M | -13.3% |
| FY2022 | -$186.5M | -44.8% |
| FY2021 | -$128.8M | -35.2% |
| FY2020 | -$95.2M | -8.3% |
| FY2019 | -$87.9M | -59.2% |
| FY2018 | -$55.2M | -230.3% |
| FY2017 | -$16.7M | -186.4% |
| FY2016 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice